JP2006525328A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006525328A5 JP2006525328A5 JP2006509943A JP2006509943A JP2006525328A5 JP 2006525328 A5 JP2006525328 A5 JP 2006525328A5 JP 2006509943 A JP2006509943 A JP 2006509943A JP 2006509943 A JP2006509943 A JP 2006509943A JP 2006525328 A5 JP2006525328 A5 JP 2006525328A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- combination
- cardiovascular disease
- prevention
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 11
- 208000024172 Cardiovascular disease Diseases 0.000 claims 8
- 238000000034 method Methods 0.000 claims 6
- 230000002265 prevention Effects 0.000 claims 6
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 claims 5
- 229960001138 acetylsalicylic acid Drugs 0.000 claims 5
- 150000001875 compounds Chemical class 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 5
- 239000002207 metabolite Substances 0.000 claims 4
- 239000000651 prodrug Substances 0.000 claims 4
- 229940002612 prodrug Drugs 0.000 claims 4
- 239000012453 solvate Substances 0.000 claims 4
- 208000004476 Acute Coronary Syndrome Diseases 0.000 claims 3
- 230000000747 cardiac effect Effects 0.000 claims 3
- 206010003658 Atrial Fibrillation Diseases 0.000 claims 2
- 206010019280 Heart failures Diseases 0.000 claims 2
- 208000026106 cerebrovascular disease Diseases 0.000 claims 2
- 208000019553 vascular disease Diseases 0.000 claims 2
- 206010002329 Aneurysm Diseases 0.000 claims 1
- 208000009447 Cardiac Edema Diseases 0.000 claims 1
- 208000006017 Cardiac Tamponade Diseases 0.000 claims 1
- 206010007513 Cardiac aneurysm Diseases 0.000 claims 1
- 206010007559 Cardiac failure congestive Diseases 0.000 claims 1
- 206010011086 Coronary artery occlusion Diseases 0.000 claims 1
- 208000000059 Dyspnea Diseases 0.000 claims 1
- 206010013975 Dyspnoeas Diseases 0.000 claims 1
- 208000010496 Heart Arrest Diseases 0.000 claims 1
- 208000035211 Heart Murmurs Diseases 0.000 claims 1
- 208000000616 Hemoptysis Diseases 0.000 claims 1
- 206010033799 Paralysis Diseases 0.000 claims 1
- 208000001871 Tachycardia Diseases 0.000 claims 1
- JALHGCPDPSNJNY-UHFFFAOYSA-N [5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-6,7-dihydro-4h-thieno[3,2-c]pyridin-2-yl] acetate;hydron;chloride Chemical compound Cl.C1CC=2SC(OC(=O)C)=CC=2CN1C(C=1C(=CC=CC=1)F)C(=O)C1CC1 JALHGCPDPSNJNY-UHFFFAOYSA-N 0.000 claims 1
- 229940045200 cardioprotective agent Drugs 0.000 claims 1
- 239000012659 cardioprotective agent Substances 0.000 claims 1
- 230000002107 myocardial effect Effects 0.000 claims 1
- 208000010125 myocardial infarction Diseases 0.000 claims 1
- 208000021090 palsy Diseases 0.000 claims 1
- 239000003223 protective agent Substances 0.000 claims 1
- 208000037803 restenosis Diseases 0.000 claims 1
- 206010042772 syncope Diseases 0.000 claims 1
- 230000006794 tachycardia Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46790303P | 2003-05-05 | 2003-05-05 | |
| PCT/US2004/011257 WO2004098713A2 (en) | 2003-05-05 | 2004-04-26 | Treating cardiovascular diseases with a compound of formula (i) (cs 747 - prasugrel; rn 150322-43-4) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006525328A JP2006525328A (ja) | 2006-11-09 |
| JP2006525328A5 true JP2006525328A5 (https=) | 2007-01-18 |
Family
ID=33435139
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006509943A Pending JP2006525328A (ja) | 2003-05-05 | 2004-04-26 | 心疾患の治療方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20060217351A1 (https=) |
| EP (1) | EP1660183A2 (https=) |
| JP (1) | JP2006525328A (https=) |
| WO (1) | WO2004098713A2 (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8137397B2 (en) * | 2004-02-26 | 2012-03-20 | Boston Scientific Scimed, Inc. | Medical devices |
| US20090156632A1 (en) * | 2005-06-17 | 2009-06-18 | John Thomas Brandt | Dosage regimen for prasugrel |
| US20080214599A1 (en) * | 2005-08-19 | 2008-09-04 | John Thomas Brandt | Use of Par-1/Par-4 Inhibitors for Treating or Preventing Vascular Diseases |
| CN101484411A (zh) * | 2006-06-27 | 2009-07-15 | 桑多斯股份公司 | 盐的新制备方法 |
| CA2672157C (en) * | 2006-12-07 | 2016-07-26 | Daiichi Sankyo Company, Limited | Method for producing solid preparation |
| US9034860B2 (en) | 2006-12-07 | 2015-05-19 | Daiichi Sankyo Company, Limited | Pharmaceutical composition containing low-substituted hydroxypropyl cellulose |
| JPWO2008069262A1 (ja) * | 2006-12-07 | 2010-03-25 | 第一三共株式会社 | 安定性が改善されたフィルムコーティング製剤 |
| CN101600431B (zh) * | 2006-12-07 | 2011-09-07 | 第一三共株式会社 | 具有改进贮存稳定性的药物组合物 |
| CA2672134C (en) | 2006-12-07 | 2015-02-10 | Daiichi Sankyo Company, Limited | Solid medicinal preparation containing mannitol or lactose |
| NZ579993A (en) * | 2007-03-02 | 2012-06-29 | Daiichi Sankyo Co Ltd | Process for production of prasugrel hydrochloride having high purity |
| JP5681485B2 (ja) | 2007-04-27 | 2015-03-11 | サイデックス・ファーマシューティカルズ・インコーポレイテッド | クロピドグレルおよびスルホアルキルエーテルシクロデキストリンを含有する製剤ならびに使用方法 |
| US20100261908A1 (en) * | 2007-11-09 | 2010-10-14 | Dr. Reddy's Laboratories Ltd. | Processes for the preparation of prasugrel , and its salts and polymorphs |
| HU230262B1 (hu) * | 2007-11-27 | 2015-11-30 | Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság | Eljárás gyógyszeripari intermedierek előállítására |
| US20090281136A1 (en) * | 2008-05-08 | 2009-11-12 | Sandeep Mhetre | Prasugrel pharmaceutical formulations |
| PL2398468T3 (pl) * | 2009-02-17 | 2017-06-30 | Krka, D.D., Novo Mesto | Kompozycje farmaceutyczne zawierające zasadę prasugrelu lub jej farmaceutycznie dopuszczalne kwasowe sole addycyjne i sposoby ich otrzymywania |
| CA2761455C (en) | 2009-05-13 | 2018-06-12 | Cydex Pharmaceuticals, Inc. | Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same |
| WO2011025881A1 (en) | 2009-08-28 | 2011-03-03 | Hercules Incorporated | Film coating composition from solid powder compounds |
| EP2275087B8 (en) * | 2010-02-22 | 2012-11-21 | Jrs Pharma GmbH+Co.kG | Prasugrel controlled release formulations |
| CN102869668A (zh) | 2010-03-09 | 2013-01-09 | 斯索恩有限公司 | 制备普拉格雷的方法 |
| EP2409685A3 (en) * | 2010-07-19 | 2012-02-01 | Sanovel Ilac Sanayi ve Ticaret A.S. | Orally-disintegrating formulations of prasugrel |
| TR201006802A1 (tr) * | 2010-08-17 | 2012-03-21 | Sanovel İlaç San. Ve Ti̇c. A.Ş. | Prasugrelin oral yolla dağılan formülasyonları. |
| CN102775422B (zh) * | 2012-03-13 | 2014-12-31 | 山东新华制药股份有限公司 | 普拉格雷中间体的一种晶型 |
| CN102993210A (zh) * | 2012-12-19 | 2013-03-27 | 苏春华 | 一种吡啶并噻吩的新化合物 |
| CN104418718B (zh) * | 2013-08-28 | 2018-04-13 | 山东新时代药业有限公司 | 一种环丙基‑2‑溴‑2‑（2‑氟苯基）乙酮的制备方法 |
| CN107304216A (zh) * | 2016-04-20 | 2017-10-31 | 陕西合成药业股份有限公司 | 噻吩吡啶类衍生物及其制备方法和用途 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3191597A (en) * | 1996-06-26 | 1998-01-14 | Sankyo Company Limited | Novel medicinal compositions of hydropyridines |
| JP3274088B2 (ja) * | 1996-08-28 | 2002-04-15 | 三共株式会社 | 環状アミン誘導体 |
| JP3907029B2 (ja) * | 1998-02-27 | 2007-04-18 | 三共株式会社 | 環状アミン誘導体を含有する医薬 |
| US6509348B1 (en) * | 1998-11-03 | 2003-01-21 | Bristol-Myers Squibb Company | Combination of an ADP-receptor blocking antiplatelet drug and a thromboxane A2 receptor antagonist and a method for inhibiting thrombus formation employing such combination |
| JP2001131067A (ja) * | 1999-08-26 | 2001-05-15 | Sankyo Co Ltd | 血小板凝集抑制剤又は動脈硬化進展抑制剤 |
| ATE339417T1 (de) * | 1999-12-15 | 2006-10-15 | Bristol Myers Squibb Co | Biphenyl - sulfonamide als duale angiotensin - endothelin - rezeptor - antagonisten |
| JP4001199B2 (ja) * | 2000-07-06 | 2007-10-31 | 第一三共株式会社 | ヒドロピリジン誘導体酸付加塩 |
| AU2001267916B2 (en) * | 2000-07-06 | 2004-09-09 | Daiichi Sankyo Company, Limited | Hydropyridine derivative acid addition salts |
| AU2002217464B2 (en) * | 2000-12-25 | 2004-12-16 | Daiichi Sankyo Company, Limited | Medicinal compositions containing aspirin |
| JP2002348235A (ja) * | 2001-03-23 | 2002-12-04 | Clinical Supply:Kk | 再狭窄予防剤 |
-
2004
- 2004-04-26 US US10/553,763 patent/US20060217351A1/en not_active Abandoned
- 2004-04-26 WO PCT/US2004/011257 patent/WO2004098713A2/en not_active Ceased
- 2004-04-26 EP EP04750031A patent/EP1660183A2/en not_active Withdrawn
- 2004-04-26 JP JP2006509943A patent/JP2006525328A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006525328A5 (https=) | ||
| US11103467B2 (en) | Method for treating depression | |
| Mercier et al. | Divergent effects of inotropic stimulation on the ischemic and severely depressed reperfused myocardium. | |
| JP2015057436A5 (https=) | ||
| RU2004126950A (ru) | Использование выделяющих co соединений при изготовлении лекарственного средства для лечения воспалительных заболеваний | |
| JP2009545560A5 (https=) | ||
| KR101675501B1 (ko) | 클로피도그렐 및 아스피린의 복합제제 | |
| HRP20140645T1 (hr) | Uporabe dpp-iv inhibitora | |
| RU2011148362A (ru) | Стабильные фармацевтические композиции и способы их применения | |
| JP2014077003A5 (https=) | ||
| HRP20220058T1 (hr) | Sastavi i metode za smanjenje velikih neželjenih kardiovaskularnih događaja | |
| JP2005537268A5 (https=) | ||
| JP2008520736A5 (https=) | ||
| RU2008148547A (ru) | Фармацевтические композиции, включающие дулоксетина гидрохлорид с замедленным высвобождением | |
| RU2005118750A (ru) | Органические соединения | |
| FI3562487T3 (fi) | Metalloentsyymi-inhibiittoriyhdisteitä | |
| CN102056603A (zh) | 决奈达隆用于预防持续性心房纤颤 | |
| JP6657420B2 (ja) | クロピドグレル及びアスピリンを含む複合製剤 | |
| JP2005508955A5 (https=) | ||
| JP2006525328A (ja) | 心疾患の治療方法 | |
| JP2014532726A5 (https=) | ||
| CN106618821B (zh) | 一种防止血管再狭窄的血管支架及其制备方法 | |
| JP2020510616A5 (https=) | ||
| JP2016516031A5 (https=) | ||
| CN101642443B (zh) | 单硝酸异山梨酯渗透泵型控释制剂及其制备方法 |